Original Query: ALL
Previous Study | Return to List | Next Study

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01629758
Recruitment Status : Completed
First Posted : June 28, 2012
Last Update Posted : March 6, 2015
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2014
  Study Completion Date : December 2014